Laboratory Reference Grade Compounds

CJC-1295 with DAC

RUO In-VitroLyophilized Powder≥99% Reference Standard
Protocol SOP↓
₱2,800.00
Out of stock
InclusionAnalytical Lab Set
Net Content2MG
Volume Discounts:Up to 20% OFF
1
SOPReconstitution Telemetry (2MG)
Diluent:mL
Concentration2.00 mg/mLin 1.0mL BAC
Standard Dose1.0 mg – 2.0 mg weekly (1000 mcg – 2000 mcg)Syringe: 100.0 units (1.00 mL)
Scale (1 Unit)20 mcgper 0.01 mL (U-100)
• Lyophilized vial onlyMonograph SOP →
CJC-1295 with DAC2MG · Analytical Lab Set
₱2,800.00
1
Technical Specification & Protocol Dossier

Analytical Standards & Laboratory Handling

Verified laboratory protocols, reconstitution parameters, and handling guidelines.

P

Pharmacological Profile & Mechanism of Action

Research Monograph

What it is: CJC-1295 with DAC is a synthetic GHRH analogue conjugated to a Drug Affinity Complex (DAC) that binds irreversibly to circulating serum albumin, extending its biological half-life to 6–8 days.

How it works: By binding to blood albumin, CJC-1295 with DAC provides continuous, 24/7 stimulation of the pituitary GHRH receptor. This drives a sustained, around-the-clock elevation in baseline growth hormone and circulating IGF-1 levels from a single weekly or bi-weekly dose.

Why researchers study it: Researched for long-acting growth hormone elevation, continuous tissue healing, sustained muscle preservation, and anti-catabolic support without requiring daily injections.

Compound & Molecular Specifications

Certificate of Analysis Standards
Target CategoryGrowth Hormone Axis
Intended ApplicationLaboratory & In-Vitro Research Only (RUO)
Physical StateLyophilized Solid Powder
CAS Registry Number863288-34-0-DAC
PubChem CID91971820↗
Molecular Weight3647.28 g/mol
Purity Specification≥99.0% (HPLC-grade)
Net Content Options2MG
Inclusion PackagesVial Only, Vial + BAC Water, Analytical Lab Set
Peptide Sequence / FormulaTetrasubstituted GHRH 1-29 with (Maleimidopropionyl)-Lysine linker at C-terminus
⚡ Pharmacodynamic Synergy·Verified Stacking Regimens

Frequently Stacked with CJC-1295 No DAC (Mod GRF 1-29)

Clinically verified combinations activating complementary physiological pathways without receptor competition.

Stacking Studio
Co-Administered Regimen

Ipamorelin (GHRP Selective)

+99 Synergy
The Somatotropic Pulse Stack: Complementary GHRH + GHRP Synergy

CJC-1295 (GHRH agonist) stimulates the synthesis and transcription of Growth Hormone in pituitary somatotropes, while Ipamorelin (selective GHSR agonist) suppresses somatostatin and triggers the vesicular release pulse. Together they produce an amplified physiological GH pulse up to 5x higher than either alone.

⏱Co-administer together 30 minutes before sleep on a strictly fasted stomach (≥2 hours after last meal) to avoid somatostatin release from carbohydrate/insulin spikes•🛡Separate syringe
15% Off bundle
Compare